Undoctored vault view

The Drug Foundation is urging caution after drug checking services at Rhythm and Vines (RnV) found paper tabs sold as LSD were in fact the potent psychedelic and stimulant, 25B-NBOH

Te Pātaka Whaioranga – Pharmac has reached provisional agreements with two different suppliers to fund two medicines to treat New Zealanders with advanced non-small cell lung cancer. The medicines are pembrolizumab (brand name Keytruda) and atezolizumab (brand name Tecentriq)

Te Aka Whai Ora welcomes formal recognition of first 11 iwi-Māori partnership boards 

Te Pātaka Whaioranga - Pharmac has today announced funding of ustekinumab (branded as Stelara) for people with inflammatory bowel disease (IBD) and the widening of funded access to infliximab (branded as Remicade) for people with IBD-associated arthritis from 1 February 2023

Te Aka Whai Ora - Māori Health Authority has made permanent appointments to three Deputy Chief Executive roles, DCE – Mātauranga Māori, DCE – Service Development and Relations and DCE – Governance and Advisory

Te Whatu Ora – Health New Zealand Chief Executive Fepulea’i Margie Apa has today announced the appointment of Peter Alsop as Chief of Staff

Six minutes of high intensity exercise may help maintain a healthy brain and delay the onset of neurogenerative disorders, research led by the University of Otago has shown

Te Pātaka Whaioranga - Pharmac has confirmed today that it will be fully funding the EpiPen brand of adrenaline auto injectors from 1 February 2023, which will benefit thousands of New Zealanders

The country’s lead health agencies will explore system-level changes to maximise the benefits of clinical trials, based on recommendations from an independent research report

Te Pātaka Whaioranga – Pharmac has set up a dedicated Māori directorate, demonstrating the strong commitment Pharmac has to ensuring equitable health outcomes for Māori